Effects of Mokuboito, a Japanese Kampo medicine, on symptoms in patients hospitalized for acute decompensated heart failure - A prospective randomized pilot study.

CONCLUSIONS: Oral administration of Mokuboito significantly improved ADHF-related symptoms. Our observations might provide the basis for a novel therapeutic strategy in hospitalized patients with ADHF. PMID: 31272834 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31272834?dopt=Abstract

Source: Journal of Cardiology - July 1, 2019 Category: Cardiology Authors: Ezaki H, Ayaori M, Sato H, Maeno Y, Taniwaki M, Miyake T, Sakurada M Tags: J Cardiol Source Type: research